Skip to Main Content

Author Details

Mara M Epstein
University of Massachusetts Chan Medical School
2011
52
14
PMIDPaper TitleJournal TitlePublished Year
36799553Multimorbidity in patients with monoclonal gammopathy of undetermined significance.Int J Cancer2023
37594966Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program.PLoS One2023
37098602A picture is worth a thousand words: advancing the use of visualization tools in implementation science through process mapping and matrix heat mapping.Implement Sci Commun2023
36720120Trends and Factors Associated with Fecal Occult Blood Test Utilization among Hispanic Adults in Puerto Rico and the United States: BRFSS 2012-2020.Cancer Prev Res (Phila)2023
36853428Patient and provider-level drivers of healthcare utilization related to a diagnosis of a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS).Cancer Causes Control2023
35304925Multi-trajectory models of serum biomarkers among patients with monoclonal gammopathy of undetermined significance.Hematol Oncol2022
35472083Demographic differences in willingness to share electronic health records in the All of Us Research Program.J Am Med Inform Assoc2022
35659860Uptake of HPV Vaccine among young adults with disabilities, 2011 to 2018.Disabil Health J2022
37096019Association Between Body Mass Index and Cancer Screening Adherence Among Latinas in the United States and Puerto Rico.Womens Health Rep (New Rochelle)2022
35933572Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.Cancer Causes Control2022
36255154A prospective analysis of red blood cell membrane polyunsaturated fatty acid levels and risk of non-Hodgkin lymphoma.Leuk Lymphoma2022
36112886Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance.Cancer Control2022
36005205Patient-Reported Experiences of Breast Cancer Screening, Diagnosis, and Treatment Delay, and Telemedicine Adoption during COVID-19.Curr Oncol2022
32383046Variation in Colorectal Cancer Screening Practices According to Cardiovascular Disease Status and Race/Ethnicity.J Racial Ethn Health Disparities2021
33899311Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM.Pharmacoepidemiol Drug Saf2021
33523236Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.J Natl Cancer Inst2021
34089470Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicity.Cancer Causes Control2021
33416902Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.Ann Hematol2021
30802944Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.Int J Cancer2020
31736189Identifying monoclonal gammopathy of undetermined significance in electronic health data.Pharmacoepidemiol Drug Saf2020
31975315Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence.Breast Cancer Res Treat2020
33284845Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool.PLoS One2020
33022699Red blood cell membrane trans fatty acid levels and risk of non-Hodgkin lymphoma: a prospective nested case-control study.Am J Clin Nutr2020
32556947Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.Cancer Causes Control2020
30967418Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients.Cancer Epidemiol Biomarkers Prev2019
31590146Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML.J Natl Compr Canc Netw2019
31487201Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network.JCO Clin Cancer Inform2019
30984796The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine.EGEMS (Wash DC)2019
29192350Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis.Cancer Causes Control2018
29930163Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies.Haematologica2018
29875079Screening mammography among nursing home residents in the United States: Current guidelines and practice.J Geriatr Oncol2018
30376847Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.BMC Health Serv Res2018
29756258A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.Int J Cancer2018
26490950Training in the Conduct of Population-Based Multi-Site and Multi-Disciplinary Studies: the Cancer Research Network's Scholars Program.J Cancer Educ2017
37592666Impact of 2012 USPSTF Screening PSA Guideline Statement: Changes in Primary Care Provider Practice Patterns and Attitudes.Urol Pract2017
28187509Dairy intake in relation to prostate cancer survival.Int J Cancer2017
28425616Statin use and risk of multiple myeloma: An analysis from the cancer research network.Int J Cancer2017
29595830Influence of Dietary Patterns on Plasma Soluble CD14, a Surrogate Marker of Gut Barrier Dysfunction.Curr Dev Nutr2017
26775038Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort.Carcinogenesis2016
27639398The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.Cancer Causes Control2016
27136063Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.Int J Cancer2016
26182945Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study.Am J Epidemiol2015
23959920Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.Int J Cancer2014
25002716Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study.J Clin Oncol2014
24844401Genetic variation across C-reactive protein and risk of prostate cancer.Prostate2014
23382116A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.Clin Cancer Res2013
23983237Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men.Cancer Epidemiol Biomarkers Prev2013
21563195Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.Prostate2012
22781428Dietary fatty acid intake and prostate cancer survival in ÿrebro County, Sweden.Am J Epidemiol2012
22710747Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.Cancer Causes Control2012
  • 1 - 50 of 52

Recommended Authors

David Geffen School of Medicine at university of california los angeles
Career Start Year 2019
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 2
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Center for Research on Health Care, University of Pittsburgh
Career Start Year 2012
Number of shared co-authors 0
San Diego State University School of Public Health
Career Start Year 2011
Number of shared co-authors 0
Georgetown University
Career Start Year 2008
Number of shared co-authors 0
School of Cancer and Pharmaceutical Sciences, King's College London
Career Start Year 2007
Number of shared co-authors 1
Perelman School of Medicine, The University of Pennsylvania
Career Start Year 2005
Number of shared co-authors 1
Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
Career Start Year 2003
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
University of California Davis
Career Start Year 2002
Number of shared co-authors 1
Mailman School of Public Health, Columbia University
Career Start Year 2001
Number of shared co-authors 4
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 2
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 1
University of Texas Medical Branch at Galveston
Career Start Year 1997
Number of shared co-authors 0
Center for Health Research, Kaiser Permanente Northwest Research Center
Career Start Year 1994
Number of shared co-authors 4
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 8
University of California irvine
Career Start Year 1988
Number of shared co-authors 12
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1987
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 0
Kaiser Permanente Southern California
Career Start Year 1986
Number of shared co-authors 2
Kaiser Permanente Northern California, University of California san francisco
Career Start Year 1985
Number of shared co-authors 8
National Cancer Institute
Career Start Year 1983
Number of shared co-authors 2
Keck School of Medicine, University of Southern California
Career Start Year 1981
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 9
University of California San Francisco
Career Start Year 1968
Number of shared co-authors 8
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 1964
Number of shared co-authors 5

Collaborators

Harvard T.H. Chan School of Public Health
Co-authored papers 12
HealthPartners Institute
Co-authored papers 11
Co-authored papers 11
Brigham and Women's Hospital
Co-authored papers 7
Co-authored papers 5
Co-authored papers 5
university of massachusetts amherst Chan Medical School
Co-authored papers 4
Henry Ford Hospital
Co-authored papers 4
Kaiser Permanente Center for Health Research
Co-authored papers 4
Research Institute
Co-authored papers 4
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 4
Co-authored papers 3
university of massachusetts amherst Chan Medical School
Co-authored papers 3
College of Human Medicine, Michigan State University
Co-authored papers 2
University of Washington Medical Center
Co-authored papers 2
Behavioral Health Services.
Co-authored papers 2
Texas A&M College of Medicine
Co-authored papers 2
Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Co-authored papers 2
Co-authored papers 2
Henry Ford Hospital, University of Pennsylvania
Co-authored papers 2
Henry Ford Hospital
Co-authored papers 2
Co-authored papers 2
University of Massachusetts Chan Medical School
Co-authored papers 2
Co-authored papers 1
Hunter College, City University of New York
Co-authored papers 1
National Institutes of Health
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
VA Boston Healthcare System
Co-authored papers 1
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 1
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 1